EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CCL21 expression is associated with immune infiltration and represents a potential therapeutic target in human tumors

Xiaoyan Li, Yurong Gu, Chunhong Liao, Yanlin Huang

Discover Oncology · 14.11.2026

DOI: 10.1007/s12672-026-06271-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 14.11.2026. Verfasst von Xiaoyan Li und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Natural Science Cultivation Foundation of the Third Affiliated Hospital of Sun Yat-sen University, Postdoctoral Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CCL21 is essential for immune surveillance and tissue homeostasis, yet its role across human cancers remains poorly understood. This study investigates the pan-cancer expression, immune correlation, and prognostic value of CCL21. CCL21 expression data were obtained from TCGA, GTEx, and CCLE. Associations with immune infiltration and immune checkpoint genes were analyzed using TIMER. Tumor-infiltrating immune subtypes were evaluated via TISIDB. KEGG enrichment and STRING analyses were performed to explore underlying mechanisms. CCL21 was significantly downregulated in most tumor types compared to normal tissues, and its expression correlated with patient prognosis. CCL21 levels showed strong positive associations with infiltrating B cells, CD4 + and CD8 + T cells, macrophages, neutrophils, and dendritic cells. Positive correlations were also observed with immune checkpoint markers including PD-1, TIM-3, and CTLA-4. Functional analyses indicated that CCL21 is involved in cytokine–cytokine interactions and chemokine signaling pathways. CCL21 is broadly downregulated in cancer and appears to play a significant role in tumor immunity. Its strong association with immune checkpoint markers and immune cell infiltration suggests that CCL21 may serve as a prognostic biomarker and a potential therapeutic target in oncology.

Förderung

  • National Natural Science Foundation of China
  • National Natural Science Cultivation Foundation of the Third Affiliated Hospital of Sun Yat-sen University
  • Postdoctoral Science Foundation of China

Zitieren

APA

Li, X., Gu, Y., Liao, C., & Huang, Y. (2026). CCL21 expression is associated with immune infiltration and represents a potential therapeutic target in human tumors. Discover Oncology. https://doi.org/10.1007/s12672-026-06271-8

Vancouver

Li X, Gu Y, Liao C, Huang Y. CCL21 expression is associated with immune infiltration and represents a potential therapeutic target in human tumors. Discover Oncology. 2026. doi:10.1007/s12672-026-06271-8

BibTeX
@article{Li2026,
  author = {Li, Xiaoyan and Gu, Yurong and Liao, Chunhong and Huang, Yanlin},
  title = {CCL21 expression is associated with immune infiltration and represents a potential therapeutic target in human tumors},
  journal = {Discover Oncology},
  year = {2026},
  doi = {10.1007/s12672-026-06271-8}
}
Kostenlos starten →